PGRMC1 and metastatic malignant neoplasm in the lymph nodes: Zhang et al.73 reported a 67.89% positive expression of PGRMC1 in breast cancer patients (74 out of 109 cases), and the expression of PGRMC1 was related to breast tumor size, lymph node metastasis, and prognoses.